Athira Pharma (ATHA) Stock Statistics & Valuation Metrics

Athira Pharma has a market cap or net worth of $15.26M. The enterprise value is -$17.00M.

Athira Pharma has 3,943,933 shares outstanding. The number of shares has decreased by -2.65% in one year.

Athira Pharma’s return on equity (ROE) is -2.16 and return on invested capital (ROIC) is -219.08%.

The current PE Ratio of Athira Pharma is ―. Athira Pharma’s PEG ratio is 0.01.

In the last 12 months, Athira Pharma had revenue of 0.00 and earned -96.94M in profits. Earnings per share was -25.20.

In the last 12 months, operating cash flow was -70.70M and capital expenditures 0.00, giving a free cash flow of -70.70M billion.

Athira Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Athira Pharma upcoming earnings date is Nov 6, 2025, After Close (Confirmed).

Athira Pharma as a current ratio of 4.18, with Debt / Equity ratio of 3.18%

In the past 12 months, Athira Pharma has paid 0.00 in taxes.

Athira Pharma EV to EBITDA ratio is 0.26, with an EV/FCF ratio of 0.25.

Athira Pharma has $29.82M in cash and marketable securities with $1.02M in debt, giving a net cash position of $28.81M billion.

Gross margin is -20.87%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Athira Pharma is $4.00, which is 11.43% higher than the current price. The consensus rating is Hold